EUVIMEDOpdag EUVIMED
Crossref

A Functional Nanocomposite Tri‐Activates Cuproptosis, Ferroptosis, and Mitophagy Death Pathway to Oppose Malignancies

Kun Deng, Wei Gao, Yu Wen, Jianliang Huang, Xuetong Li, Xiaoxin Yang, Minghua Wu iD

Advanced Healthcare Materials · 2026-02 · 15 (6)

DOI: 10.1002/adhm.202503530 ↗

At a glance

Journal article in Advanced Healthcare Materials, published online on 2025-11-06. Written by Kun Deng and 6 co-authors. Institution: The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Central South University, Changsha, Hun…. Major MEDLINE topics: Ferroptosis, Copper, Mitophagy, Nanocomposites. Cited 18 times so far (Crossref); 58 references. Funded by: National Natural Science Foundation of China, Scientific Research Program of FuRong Laboratory, Hunan Provincial Graduate Research and Innovation Projects.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Metal ion dyshomeostasis represents a therapeutic vulnerability in cancer, yet simultaneous targeting of multiple metal‐dependent death pathways remains challenging. Herein, a pH‐responsive copper‐based metal‐organic framework nanoplatform (Cu‐MOF@DPCPX) is engineered to co‐trigger cuproptosis, ferroptosis, and mitophagy through tumor‐specific copper overload. The system leverages acidic tumor microenvironments for targeted degradation, releasing Cu 2 ⁺. The liberated Cu 2 ⁺ depletes overexpressed glutathione (GSH) to disrupt redox homeostasis and generates toxic Cu⁺ that initiates dual catalytic cycles. 1) Cu⁺ accumulation promotes lipoylated protein aggregation and Fe‐S cluster loss, driving cuproptosis; 2) Cu⁺‐mediated Fenton‐like reactions convert endogenous H 2 O 2 into hydroxyl radicals (·OH) and downregulate GPX4 to induce ferroptosis. Crucially, mitochondrial damage from these pathways activates mitophagy, which releases sequestered copper to establish a self‐amplifying death cascade. In vivo, Cu‐MOF@DPCPX demonstrates potent tumor suppression across multiple tumor models (4T1‐breast, LLC‐lung, PAN02‐pancreatic, GL261‐glioblastoma), while reprogramming immunosuppressive microenvironments via increased CD8⁺ T‐cell infiltration and M1 macrophage polarization. This triple‐pathway activation strategy overcomes monotherapy limitations and establishes a paradigm for metal‐ion‐based multimodal oncotherapy.

Subjects

MeSH terms (MEDLINE)

FerroptosisCopperMitophagyNanocompositesNeoplasmsAnimalsHumansMetal-Organic FrameworksMiceCell Line, TumorFemale

Author keywords

copper‐based metal organic frameworkmetal ion dyshomeostasisnanocatalystpH‐responsivetumor therapy

Substances

CopperMetal-Organic Frameworks

Authors and institutions

  • The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Central South University, Changsha, Hunan, 410008, China.
  • The Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, Central South University,…
  • FuRong Laboratory, Central South University, Changsha, Hunan, 410078, China.
  • Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
  • Department of Radiology, the Second Xiangya Hospital, Central South University, Changsha, Hunan, 410000, China.
  • Xiangya School of Public Health, Central South University, Changsha, Hunan, 410013, China.

ORCID profiles: Minghua Wu

Funding

  • National Natural Science Foundation of China
  • Scientific Research Program of FuRong Laboratory
  • Hunan Provincial Graduate Research and Innovation Projects

Cite

APA

Deng, K., Gao, W., Wen, Y., Huang, J., Li, X., Yang, X., & Wu, M. (2026). A Functional Nanocomposite Tri‐Activates Cuproptosis, Ferroptosis, and Mitophagy Death Pathway to Oppose Malignancies. Advanced Healthcare Materials, 15(6). https://doi.org/10.1002/adhm.202503530

Vancouver

Deng K, Gao W, Wen Y, Huang J, Li X, Yang X, et al. A Functional Nanocomposite Tri‐Activates Cuproptosis, Ferroptosis, and Mitophagy Death Pathway to Oppose Malignancies. Advanced Healthcare Materials. 2026;15(6). doi:10.1002/adhm.202503530

BibTeX
@article{Deng2026,
  author = {Deng, Kun and Gao, Wei and Wen, Yu and Huang, Jianliang and Li, Xuetong and Yang, Xiaoxin and Wu, Minghua},
  title = {A Functional Nanocomposite Tri‐Activates Cuproptosis, Ferroptosis, and Mitophagy Death Pathway to Oppose Malignancies},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  volume = {15},
  number = {6},
  doi = {10.1002/adhm.202503530}
}
Start for free →